Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results from Two Phase 3 Studies.

Bimzelx (bimekizumab-bkzx) - UCB

http://www.ncbi.nlm.nih.gov/pubmed/42297437

Alexander Marten; Atul Deodhar; Chetan Prajapati; Désirée van der Heijde; Filip Van den Bosch; Huji Xu; Jason Coarse; Lianne S Gensler; Marina Magrey; Myriam Manente; Tetsuya Tomita; Walter P Maksymowych; Xenofon Baraliakos

Jun 16, 2026